Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence-Based Recommendations. (2020)

First Author: Marques N
Attributed to:  Discovering the causes of mutation-negative hypertrophic cardiomyopathy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/jaha.120.016614

PubMed Identifier: 32969287

Publication URI: http://europepmc.org/abstract/MED/32969287

Type: Journal Article/Review

Volume: 9

Parent Publication: Journal of the American Heart Association

Issue: 19

ISSN: 2047-9980